Achillion Pharma (ACHN) Reports Q3 Loss of $0.15
Tweet
Share
E-mail
Get Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) reported Q3 EPS of ($0.15), versus ($0.16) reported last year.
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- SL Green Realty (SLG) PT Raised to $57 at Truist Securities
- Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
